C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1992
10/13/1992	US5154924 Method for delivering a neuropharmaceutical agent across the blood brain barrier to the brain of a host
10/13/1992	US5154923 Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions
10/13/1992	US5154921 Removing cells from animal, contacting with polypeptide growth factor, GRO
10/13/1992	CA2083702A1 Endopeptidase
10/13/1992	CA1308864C Serine protease inhibitors
10/13/1992	CA1308680C Method of recovering microbially produced recombinant ricin toxin a chain
10/13/1992	CA1308677C Monoclonal antibody capable of recognizing arteriosclerotic lesions and agents for detecting and treating arteriosclerosis
10/13/1992	CA1308676C Anti-human igg (immunoglobulin g) monoclonal antibody and process for preparing the same
10/12/1992	WO1992021700A1 Novel calcitonin, and production and use thereof
10/12/1992	CA2065748A1 Isolation and purification of lantibiotics
10/11/1992	WO1992018641A1 Interleukin-8 receptors and related molecules and methods
10/11/1992	WO1992018621A1 Proteinaceous lipid-containing particles
10/11/1992	WO1992018620A1 Attenuated poliovirus and vaccines thereof
10/11/1992	CA2108141A1 Attenuated poliovirus and vaccines thereof
10/11/1992	CA2107879A1 Proteinaceous lipid-containing particles
10/11/1992	CA2107682A1 Interleukin-8 receptors and related molecules and methods
10/11/1992	CA2065690A1 Non-a, non-b hepatitis related antigens, detection systems, polynucleotides and polypeptides
10/11/1992	CA2042318A1 Attenuated viruses
10/10/1992	WO1992018535A1 Endometrial antigen, composition, test kit and method for endometrial antibody determination
10/10/1992	CA2081900A1 Endometrial antigen, composition, test kit and method for endometrial antibody determination
10/10/1992	CA2065602A1 Method and kit for measuring anti-ebna antibodies
10/10/1992	CA2062675A1 Endometrial antigen, composition, test kit and method for endometrial antibody determination
10/09/1992	WO1992017195A1 Novel peptide compositions and uses therefor
10/09/1992	CA2107674A1 Novel peptide compositions and uses therefor
10/07/1992	EP0507723A1 Xylanase, corresponding recombinant DNA sequence, xylanase containing agent, and use of the agent
10/07/1992	EP0507698A1 Histone promotors
10/07/1992	EP0507615A1 Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
10/07/1992	EP0507179A2 Equine herpes viruses (EHV) containing foreign DNA, process for their preparation and their use as vaccines
10/07/1992	EP0507170A2 Calcium channel subtype specific of human neuronal tissue and its use
10/07/1992	EP0506971A1 Peptide with activity of inhibiting phospholipase a2 originating in inflamed part
10/07/1992	EP0506963A1 Production of human basic fgf mutein
10/07/1992	EP0506893A1 Diagnosis and treatment of diseases
10/07/1992	EP0506890A1 Recombinant thyrotropin receptor
10/07/1992	EP0506868A1 Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine.
10/07/1992	EP0506854A1 An improved toxin for construction of immunotoxins
10/07/1992	EP0506845A1 Uncharged morpholino-based polymers having achiral intersubunit linkages
10/07/1992	EP0506821A1 Hybrid protein c
10/07/1992	EP0506820A1 Neutrophil chemoattractants
10/07/1992	EP0506818A1 Method of covalently bonding proteins to hydrophilic surfaces.
10/07/1992	EP0506815A1 Mucin nucleotides
10/07/1992	EP0506785A1 Improved treatment of autoimmune diseases by aerosol administration of auto antigens
10/07/1992	EP0506766A1 Hepatocellular carcinoma oncogene
10/07/1992	EP0506763A1 Site-specific recombination of dna in plant cells
10/07/1992	EP0506757A1 A recombinant human factor viii derivative
10/07/1992	EP0506756A1 Transformed cell lines
10/07/1992	EP0506755A1 Polypeptides having serine protease inhibitor activity and dna coding therefor
10/07/1992	EP0213180B1 Neovascularization inhibitors and methods for their production and use
10/07/1992	EP0185092B1 Process for preparing 5'-guanylic acid
10/06/1992	WO1992017503A1 Method for the production of collagen; collagen produced through the method and use of collagen
10/06/1992	WO1992017492A1 PLATELET AGGREGATION INHIBITORS HAVING HIGH SPECIFICITY FOR GP IIbIII¿a?
10/06/1992	USRE34090 Polypeptide cartilage-inducing factors found in bone
10/06/1992	US5153312 Respiratory system disorders
10/06/1992	US5153311 Immunogenic glycoproteins of human cytomegalovirus gCII
10/06/1992	US5153310 Il-2 analogs containing n-linked glycosylation sites
10/06/1992	US5153308 S-sulfonated calcitonin derivatives
10/06/1992	US5153265 Conjugation of polymer to colony stimulating factor-1
10/06/1992	US5153176 Substituted lysine-proline-arginine peptide
10/06/1992	US5153175 Method of inducing sleep with GHRH complementary peptide compositions
10/06/1992	US5153129 Immunogenic purified protease extracted form malarial parasites which react with protective antibodies orginating form monkeys resistance to human parasites
10/06/1992	US5152982 Compositions and methods for FeLV vaccination
10/06/1992	US5152784 Binders for heparin, cellular adhesion promoters
10/06/1992	CA2107680A1 Method for the production of collagen; collagen produced through the method and use of collagen
10/06/1992	CA2106314A1 Platelet aggregation inhibitors having high specification for gpiibiiia
10/06/1992	CA1308377C Complex of polyethyleneglycol and tissue plasminogen activator
10/03/1992	WO1992017573A1 Xylanase, corresponding recombinant dna sequence, xylanase containing agent, and use of the agent
10/03/1992	CA2106484A1 Xylanase, corresponding recombinant dna sequence, xylanase containing agent, and use of the agent
10/01/1992	WO1992017025A2 GnRH ANALOGS
10/01/1992	WO1992016837A1 Detection and treatment of ulcerative colitis
10/01/1992	WO1992016660A1 Methods for detection and treatment of cancer
10/01/1992	WO1992016656A1 Gene mutated in colorectal cancer of humans
10/01/1992	WO1992016638A1 Transduction vehicles for transferring dna to a mammalian cell
10/01/1992	WO1992016637A1 Biological control agents
10/01/1992	WO1992016636A1 Recombinant virus vectors encoding human papillomavirus proteins
10/01/1992	WO1992016628A1 Polypeptides from mycobacterium paratuberculosis
10/01/1992	WO1992016626A1 Equine epidermal growth factor
10/01/1992	WO1992016625A1 Purification of active and inactive/latent forms of plasminogen activator inhibitor-1
10/01/1992	WO1992016624A1 Monoclonal antibody against lps core
10/01/1992	WO1992016621A1 Novel beta integrin subunit
10/01/1992	WO1992016620A1 Human follicle stimulating hormone receptor
10/01/1992	WO1992016619A1 Expression of influenza nucleoprotein antigens in baculovirus
10/01/1992	WO1992016618A1 Gene construct for production of transgenic fish
10/01/1992	WO1992016616A1 Malaria recombinant poxvirus vaccine
10/01/1992	WO1992016563A1 Monoclonal antibodies recognizing lymphocyte function associated antigen-3
10/01/1992	WO1992016561A1 Ovine adipocyte antigens and their use in the immunological control of fat
10/01/1992	WO1992016560A1 Cns cell differentiation factor, its preparation and use
10/01/1992	WO1992016558A1 Cell surface receptors homologous to coagulation factors v and viii
10/01/1992	WO1992016557A1 Recombinant human factor viii derivatives
10/01/1992	WO1992016556A1 Derivatives opf gp160 and vaccines based on gp160 or a derivative thereof, containing an adjuvant
10/01/1992	WO1992016554A1 Protein allergens of the species cynodon dactylon
10/01/1992	WO1992016553A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor
10/01/1992	WO1992016547A1 Controlling nk-1 receptor-mediated responses and related diagnostics
10/01/1992	WO1992016543A1 NORWALK VIRUS HUMAN GASTROENTERITIS AGENT AND MOLECULAR CLONING OF CORRESPONDING cDNAs
10/01/1992	WO1992016300A1 Lipid fractionation
10/01/1992	WO1992016226A1 Il-1 inhibitors
10/01/1992	WO1992016225A1 Antiplatelet and antithrombotic activity of platelet glycoprotein ib receptor fragments
10/01/1992	WO1992016223A1 Production of gonorrheal pi proteins and vaccines
10/01/1992	WO1992016220A1 Controlling nk-2 receptor-mediated responses and relates diagnostics
10/01/1992	DE4110405A1 Verfahren zum nachweis der differenzierung und der invasivitaet von karzinomzellen A method for detecting the differentiation and invasiveness of carcinoma cells
10/01/1992	CA2367129A1 Gene construct for production of transgenic fish
10/01/1992	CA2106587A1 Biological control agents

1 ... 2716 2717 2718 2719 2720 2721 2722 2723 2724 2725 2726 2727 2728 2729 2730 2731 2732 2733 2734 2735 2736 ... 2916